D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Caterpillar
CAT
$361B
| $219M | 0.19% |
663,058
+197,241
| +42% | +$70.3M |
|
102
PUT
ASML
ASML
$596B
| $219M | 0.19% |
329,800
+9,100
| +3% | +$6.62M |
|
103
Biogen
BIIB
$30.9B
| $217M | 0.19% |
1,585,572
-24,327
| -2% | -$3.48M |
|
104
CALL
Costco
COST
$432B
| $216M | 0.19% |
228,600
-203,400
| -47% | -$198M |
|
105
Best Buy
BBY
$19B
| $216M | 0.19% |
2,933,937
+956,546
| +48% | +$78.9M |
|
106
Canadian Natural Resources
CNQ
$96.9B
| $215M | 0.19% |
6,987,672
+4,236,003
| +154% | +$128M |
|
107
Sherwin-Williams
SHW
$83.5B
| $214M | 0.19% |
613,873
-589,266
| -49% | -$207M |
|
108
Philip Morris
PM
$309B
| $212M | 0.19% |
1,338,687
-402,176
| -23% | -$57M |
|
109
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
| $212M | 0.19% |
4,274,400
+2,045,800
| +92% | +$102M |
|
110
Colgate-Palmolive
CL
$74.8B
| $211M | 0.19% |
2,252,162
+1,263,023
| +128% | +$113M |
|
111
Constellation Energy
CEG
$92.1B
| $211M | 0.19% |
1,045,733
-1,614,896
| -61% | -$433M |
|
112
Intercontinental Exchange
ICE
$87.2B
| $211M | 0.19% |
1,221,941
+144,145
| +13% | +$23.6M |
|
113
GE Aerospace
GE
$364B
| $211M | 0.19% |
1,052,358
-513,488
| -33% | -$101M |
|
114
DexCom
DXCM
$29B
| $210M | 0.19% |
3,081,769
-448,364
| -13% | -$36.6M |
|
115
Brinker International
EAT
$8.82B
| $208M | 0.19% |
1,396,926
-454,531
| -25% | -$69.9M |
|
116
Northrop Grumman
NOC
$76B
| $208M | 0.19% |
405,937
-242,331
| -37% | -$116M |
|
117
CALL
Goldman Sachs
GS
$289B
| $204M | 0.18% |
373,400
+18,700
| +5% | +$11.3M |
|
118
Edison International
EIX
$30.3B
| $202M | 0.18% |
3,434,713
+2,961,828
| +626% | +$170M |
|
119
Astera Labs
ALAB
$42.8B
| $201M | 0.18% |
3,376,245
+929,384
| +38% | +$86M |
|
120
PUT
Pfizer
PFE
$143B
| $201M | 0.18% |
7,944,900
-3,175,400
| -29% | -$83.1M |
|
121
Sprouts Farmers Market
SFM
$7.44B
| $199M | 0.18% |
1,301,950
+24,197
| +2% | +$3.61M |
|
122
JPMorgan Chase
JPM
$916B
| $199M | 0.18% |
810,125
+115,354
| +17% | +$29.4M |
|
|
MRSH
123
Marsh
MRSH
$94.3B
| $197M | 0.18% |
806,914
+461,843
| +134% | +$105M |
|
124
Medtronic
MDT
$112B
| $196M | 0.17% |
2,176,381
+103,175
| +5% | +$9.23M |
|
125
Johnson & Johnson
JNJ
$640B
| $195M | 0.17% |
1,173,990
+201,980
| +21% | +$31.6M |
|
Similar funds
D.E. Shaw & Co's Q1 2025 Portfolio in Review
As of Q1 2025, D.E. Shaw & Co held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- D.E. Shaw & Co's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- D.E. Shaw & Co added most to GE Vernova in Q1 2025, an estimated $686M increase.
- D.E. Shaw & Co's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- D.E. Shaw & Co opened 569 new positions and closed 704 in Q1 2025.
- D.E. Shaw & Co's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.